News
The big-bank earnings reports due this week mark the quasi-official start to the second-quarter earnings season. Analysts ...
2d
Zacks Investment Research on MSNThe PNC Financial Services Group (PNC) Q2 Earnings Preview: What You Should Know Beyond the Headline EstimatesWall Street analysts forecast that The PNC Financial Services Group, Inc (PNC) will report quarterly earnings of $3.56 per share in its upcoming release, pointing to a year-over-year increase of 7.9%.
Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...
10d
Barchart on MSNEarnings Preview: What To Expect From Edwards Lifesciences' ReportIrvine, California-based Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced ...
Pfizer (PFE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment analysis of PFE stock.
Pfizer's cost-cutting boosts earnings despite revenue miss. Discover its growth strategy, strong drug portfolio & potential 29% upside. Click here to read.
Looking at the earnings estimates from analysts and key items to watch in Nike's Q4 financial results.
To track all earnings releases for Carnival visit their earnings calendar on our site. This article was generated by Benzinga's automated content engine and reviewed by an editor.
For the current quarter, Pfizer is expected to post earnings of $0.57 per share, indicating a change of -5% from the year-ago quarter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results